Health care analyst: How to play the current biotech market ahead of earnings

Welcome to the February 1 edition of This Week on Estimize. We are pleased to be joined by Joe McCann, founder of Slingshot Insights. In this episode, Leigh and Joe discuss the current state of the health care industry, and look at quarterly expectations for upcoming biotech and pharma companies such as Gilead Sciences, Merck, Biogen Idec, Celgene and Pfizer.

To access the Slingshot Insight projects mentioned by Joe on today's podcast, please click below!

1. Understanding the impact of Merck's ZEPATIER on the HCV market as it now competes with HARVONI and Viekira Pak
2. Making sense of the NASH market and where the leading development compounds from Intercept and GenFit stand

Want to cull similar insights as were highlighted in this podcast? Come trial the Estimize Screener free for 14 days.